Bullish
Achieve Life Sciences has appointed three former Verona Pharma executives, Christopher Martin, Mark Zappia, and Jim Willis, to its board and commercia...
Bullish
Achieve Life Sciences (ACHV) reported a Q1 2026 net loss of $10.2 million but closed a significant private placement of up to $354 million, with $180 ...
Bullish
Achieve Life Sciences announced its first-quarter 2026 financial results, highlighted by a successful private placement of up to $354 million to fund ...
Achieve Life Sciences' stock declined following its announcement of a capital raise totaling $45 million. The company priced an underwritten public of...